Martin Gibson

Martin Gibson is a Venture Partner at Accel in London, United Kingdom, where he focuses on technology investments across sectors including artificial intelligence and financial technology. Since joining the firm in 2009, he has targeted pre-seed through Series B+ funding rounds, deploying check sizes ranging from $1 million to $70 million. Before his tenure at Accel, Gibson served as a Partner at Atlas Venture and worked as a General Manager at Scientific Generics, which is now known as Sagentia. He began his professional career as an engineer at early-stage networking and wireless startups such as Cellstack and Madge Networks, and he holds degrees from Cambridge University and the Cranfield School of Management. His current investment strategy leverages this early technical foundation and formal business training to identify and support high-growth software, biotechnology, and cybersecurity enterprises.